Navigation Links
University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
Date:9/6/2007

ALEXANDRIA, Va., Sept. 6 /PRNewswire-USNewswire/ -- The University of Texas at Austin's Center for Pharmacoeconomic Studies released a study today called the "Length of Prescription Drug Payment Times by Medicare Part D Plans." It provides incontrovertible evidence of the slow reimbursement pharmacies have endured with Medicare Part D prescription drug claims. The study demonstrates the need for the Senate and House to pass S.1954, the Pharmacy Access Improvement Act (PhAIM) of 2007, and H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007. The bills are designed to end the detrimental payment practice that threatens our frontline health care practitioners and their patients.

"This is the first study I know of that thoroughly examines the payment times for Medicare Part D prescription drug claims data," said Kristen Richards, PhD, RPh, research associate at the University of Texas at Austin's Center for Pharmacoeconomic Studies. "It clearly shows that the community pharmacies in this study did not receive payment for a substantial proportion of their 2006 Medicare Part D claims within a 30-day time period."

The study calculated the time between when pharmacies submit claims and when pharmacies received payment for those claims in 2006. The data are of approximately 3 million Part D claims, with over 600,000 coming from community pharmacies and 2.3 million coming from chain drug stores. There were 145 community pharmacies and 17 chain drug firms whose records were examined. Importantly, the study's data represents the optimum payment scenario for pharmacies since the examined claims were both submitted and paid electronically, as opposed to the majority of claims that are paid by mail, which create an even longer payment time.

The study found that 50.0 percent of community pharmacy claims were paid more than 30 days after adjudication, including 17.1 percent where payment took over 60 days. <
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Researchers at Cornell University as been reported using research fund by false claims
2. A new study by John Hopkins University proposes formula for good health
3. James Cook University urges more medical seats
4. Pill splitting program of University of Michigan can save money
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Yale University guidelines for Physicians and Pharmaceutical industry
7. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
8. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
9. Hwang Woo Suk Suspended By Seoul National University
10. Vladeck to head the University of Medicine and Dentistry of New Jersey
11. Rice University wins Prestigious Grants from HHMI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Newswire-USNewswire/ -- New research at West Virg... spitless tobacco product aimed at young adults is...RJ Reynolds, Camel Snus - touted as a socially acc...singly high levels of nicotine. , , "Camel ...products," said Bruce Adkins of the state Division...
(Date:11/21/2008)...swire-USNewswire/ -- U.S. News & World Report ...NCQA) ranked BlueChoice(R) HealthPlan of South Car...ans(TM), published in U.S. News & World Report...l ranking ranks the nation,s best health plans bas...QA accreditation scores. NCQA and U.S. News & ...
(Date:11/21/2008)...swire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NY...overwhelmingly approved the proposals submitted to...Pharmaceuticals Industries Ltd. (Nasdaq: TEVA )....elming support of the transaction by the Barr shar...nd CEO. "We are pleased with the progress that we ...
(Date:11/21/2008)...y diseaseits cause remains a mysteryswept into Ath...citizens, soldiers and refugees of the war then ra...with corpses, social order broke down. Over the ne...ens lost a third of its population. It lost the wa...f the end of the Golden Age of Greece. , The Pl...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...ons running at double the number of what they were...e reached an all time high//.Deaths due to alcohol...ast five years, Government sources revealed. Off...compiled for the NHS, found that 35,400 people wer...
...aving several older brothers increases the chances...t adds //weight to the idea of a biological basis ...rock University in St Catharines, Canada said, "It...and other studies suggest that there is probably a...
...eported by residents living near the former VA Tec... the massive fire which ripped// through this indu...mon health problems such as eczema, asthma, psoria...r environment and health experts have found no evi...
...re found to be associated with reduced length of a... community-acquired //pneumonia (CAP) – Study find...ed to be a good indicator for early discontinuance...red with other parameters. The study, which is th...
Other Medicine News:Health News:Alcohol-Related Illnesses On The Rise 2Health News:No Clue to Cause of Mystery Illnesses 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 3
(Date:11/20/2008)... New Jersey American Water has lifted the precaut...he following municipalities in Middlesex, Somerset..., , , Dunellen , Edison , ...lainfield , , , , Somerset County ,...er , Green Brook , Hillsborough , ...
(Date:11/20/2008)...ewswire-FirstCall/ -- Arpida (SWX:,ARPN) announce...mittee of the,U.S. Food and Drug Administration (...travenous iclaprim, an antibiotic currently in dev...icated skin and skin structure infections,(cSSSIs... Staphylococcus,aureus (MRSA). , Arpida re...
(Date:11/20/2008)...tCall/ -- Duska Therapeutics,Inc., (OTC Bulletin...ed its,pivotal Phase 3 ATPace clinical trial prot...nt (SPA) procedure with the U.S. Food and Drug Adm...n agreement with the FDA, Duska intends to initiat...ntrolled and randomized Phase 3,clinical trial wi...
(Date:11/20/2008)...PAREXEL International Corporation (Nasdaq: PRXL ...vider, today announced that it has opened an offic...nd clinical research capabilities. With the additi...hroughout five important biopharmaceutical centers...razil, Chile, and Mexico. This expansion further s...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Chemo for Mesothelioma Offers Limited Survival Benefits 19551 1Chemo for Mesothelioma Offers Limited Survival Benefits 19551 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 1Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 3Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 4Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 5Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 6Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 7Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 8Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 9AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 1AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 1Senetek PLC Reports First Quarter 2008 Financial Results 5462 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 3
...D Are at High,Risk , ,WASHINGTON, March 9, 2007 ...family history of end-stage renal disease (ESRD), ...sk of developing,kidney disease themselves, report...iety of Nephrology. , "A family history of kidney ... are also at substantially higher risk of,ESRD," c...
...07 /PRNewswire-FirstCall/ - Chemokine,Therapeutics... , a,biotechnology company developing chemokine-ba...d vascular disease today announced,positive prelim...se-escalation portion of its Phase Ib/II clinical ...g candidate. No dose,limiting toxicities were obse...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 3Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 4Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 5
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...even digital models cover the range from 2ul to 50...ume lock design prevents inadvertent volume change...ip. Whole pipette is autoclavable at 121C(250F). ...ropylene. Suitable for one-handed operation. Aut...
...he AlphaPette Pipettor is the #1 Pipettor for sub-...comfort, and reliability. Continuously adjustable....dout sub-micrometer. Easy interchangeable ejector ...le rapid pipet tip ejector with three different le...
Medicine Products: